$0.9551
-0.04-4.30%
At close: -
$0.9551
0.000.00%
After Hours: Dec 20, 5:09 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Spero Therapeutics in recent months.
Browse guidance and forecast on all stocks.